ARHGAP10 and autoimmune encephalitis: Therefore, we hypothesised that cross-reactivity of ARHGAP26-IgG/anti-Ca may render ARHGAP10 an additional immune target in patients with ACA and, possibly, other forms of autoimmune encephalitis associated with ARHGAP26-IgG/anti-Ca seropositivity.